Appropriate Use of Skin Substitutes

This session will address how skin substitutes (cellular/tissue-based products) are an adjunctive therapy to consider after a patient fails to improve with the standard of care. These products can be very useful in achieving wound closure, but only in specific situations. The use of these products has come under increasing scrutiny by CMS and other insurers due to concerns over fraud, waste, and abuse. Attendees will review appropriate indications and suggested documentation language to support audits and prior authorization requests.